Pretreatment With Fragments of Substance-P or With Cholecystokinin Differentially Affects Recovery From Sub-Total Nigrostriatal 6-Hydroxydopamine Lesion
The neuropeptide substance P is known to have mnemogenic and reinforcing actions and can exert neurotrophic and regenerative effects in vitro as well as in vivo. Furthermore, our previous work in the rat showed that either pre- or post-lesion treatment with substance P can promote functional recove...
| Published in: | Neural Plasticity |
|---|---|
| Main Authors: | S. Nikolaus, J. P. Huston, R. K. W. Schwarting |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Online Access: | http://dx.doi.org/10.1155/NP.1999.77 |
Similar Items
Characterization of fetal antigen 1/delta-like 1 homologue expressing cells in the rat nigrostriatal system: effects of a unilateral 6-hydroxydopamine lesion.
by: Rémy Liechti, et al.
Published: (2015-01-01)
by: Rémy Liechti, et al.
Published: (2015-01-01)
l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
by: Christian Winkler, et al.
Published: (2002-07-01)
by: Christian Winkler, et al.
Published: (2002-07-01)
GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
by: Susanne Nikolaus, et al.
Published: (2018-03-01)
by: Susanne Nikolaus, et al.
Published: (2018-03-01)
Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure
by: Marina Yu. Kopaeva, et al.
Published: (2021-01-01)
by: Marina Yu. Kopaeva, et al.
Published: (2021-01-01)
Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat
by: Susanne Nikolaus, et al.
Published: (2021-08-01)
by: Susanne Nikolaus, et al.
Published: (2021-08-01)
Subtle Cardiovascular Dysfunction in the Unilateral 6-Hydroxydopamine-Lesioned Rat
by: K. Slack, et al.
Published: (2010-01-01)
by: K. Slack, et al.
Published: (2010-01-01)
Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas
by: Jill P. Smith, et al.
Published: (2021-11-01)
by: Jill P. Smith, et al.
Published: (2021-11-01)
Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice
by: Juntao Cui, et al.
Published: (2024-02-01)
by: Juntao Cui, et al.
Published: (2024-02-01)
Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence
by: Wen Di, et al.
Published: (2012-06-01)
by: Wen Di, et al.
Published: (2012-06-01)
Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice
by: Nan Zhang, et al.
Published: (2024-05-01)
by: Nan Zhang, et al.
Published: (2024-05-01)
Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells
by: Karim El-Kouhen, et al.
Published: (2009-01-01)
by: Karim El-Kouhen, et al.
Published: (2009-01-01)
Nigrostriatal loop - from basics and beyond
by: Mariana H.G. Monje, et al.
Published: (2024-06-01)
by: Mariana H.G. Monje, et al.
Published: (2024-06-01)
Epothilone B Benefits Nigrostriatal Pathway Recovery by Promoting Microtubule Stabilization After Intracerebral Hemorrhage
by: Yang Yang, et al.
Published: (2018-01-01)
by: Yang Yang, et al.
Published: (2018-01-01)
BRAIN CHOLECYSTOKININ SYSTEM IN NEUROTIC PATHOLOGY
by: R.V. Lutsenko, et al.
Published: (2023-04-01)
by: R.V. Lutsenko, et al.
Published: (2023-04-01)
Cholecystokinin elevates mouse plasma lipids.
by: Lichun Zhou, et al.
Published: (2012-01-01)
by: Lichun Zhou, et al.
Published: (2012-01-01)
Time-dependent alterations in the rat nigrostriatal system after intrastriatal injection of fibrils formed by α–Syn and tau fragments
by: Xiaoman Yang, et al.
Published: (2022-11-01)
by: Xiaoman Yang, et al.
Published: (2022-11-01)
Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
by: Pabla Aguirre, et al.
Published: (2015-01-01)
by: Pabla Aguirre, et al.
Published: (2015-01-01)
Nigrostriatal iron accumulation in the progression of Parkinson’s disease
by: M. López-Aguirre, et al.
Published: (2025-04-01)
by: M. López-Aguirre, et al.
Published: (2025-04-01)
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
by: Jiewen Qiu, et al.
Published: (2023-01-01)
by: Jiewen Qiu, et al.
Published: (2023-01-01)
Fenofibrate reduces food intake via cholecystokinin
Published: (2012-12-01)
Published: (2012-12-01)
The Role of Cholecystokinin in Peripheral Taste Signaling in Mice
by: Ryusuke Yoshida, et al.
Published: (2017-10-01)
by: Ryusuke Yoshida, et al.
Published: (2017-10-01)
Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-12-01)
by: Marie-Thérèse Armentero, et al.
Published: (2006-12-01)
Cholecystokinin enhances visceral pain-related affective memory via vagal afferent pathway in rats
by: Cao Bing, et al.
Published: (2012-06-01)
by: Cao Bing, et al.
Published: (2012-06-01)
Expression of Concern: Epothilone B Benefits Nigrostriatal Pathway Recovery by Promoting Microtubule Stabilization After Intracerebral Hemorrhage
Published: (2025-10-01)
Published: (2025-10-01)
Nigrostriatal dopamine pathway regulates auditory discrimination behavior
by: Allen P. F. Chen, et al.
Published: (2022-10-01)
by: Allen P. F. Chen, et al.
Published: (2022-10-01)
Corrigendum: Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
by: Jiewen Qiu, et al.
Published: (2024-10-01)
by: Jiewen Qiu, et al.
Published: (2024-10-01)
Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease
by: Cecilia M. Fox, et al.
Published: (2007-01-01)
by: Cecilia M. Fox, et al.
Published: (2007-01-01)
Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067]
by: K.N. Westlund, et al.
Published: (2023-08-01)
by: K.N. Westlund, et al.
Published: (2023-08-01)
Neuropeptide cholecystokinin: a key neuromodulator for hippocampal functions
by: Fengwen Huang, et al.
Published: (2025-07-01)
by: Fengwen Huang, et al.
Published: (2025-07-01)
Expression of gastrin and cholecystokinin B receptor in Lateolabrax maculatus
by: Tingwen Cui, et al.
Published: (2023-09-01)
by: Tingwen Cui, et al.
Published: (2023-09-01)
Cholecystokinin-A signaling regulates automaticity of pacemaker cardiomyocytes
by: Hongmei Ruan, et al.
Published: (2023-12-01)
by: Hongmei Ruan, et al.
Published: (2023-12-01)
Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa.
by: Ulrich Cuntz, et al.
Published: (2013-01-01)
by: Ulrich Cuntz, et al.
Published: (2013-01-01)
The pre-teatment effect of voluntary exercise by GDNF on lesion injectioned by 6- hydroxydopamine in brain stem of male rats
Abstract
by: راضیه محمدی, et al.
Published: (2014-04-01)
by: راضیه محمدی, et al.
Published: (2014-04-01)
Inhibition of PTPRS function does not affect the survival or regeneration of dopaminergic neurons but alters synaptic function in the nigrostriatal pathway
by: Joshua Peter, et al.
Published: (2025-09-01)
by: Joshua Peter, et al.
Published: (2025-09-01)
The action of prolyl-leucyl-glycinamide (PLG) on the nigrostriatal pathway of the rat
by: João S. Pereira, et al.
Published: (1990-06-01)
by: João S. Pereira, et al.
Published: (1990-06-01)
Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity
by: Leyre Ayerra, et al.
Published: (2024-04-01)
by: Leyre Ayerra, et al.
Published: (2024-04-01)
MRI Findings in Parkinson’s Disease: Radiologic Assessment of Nigrostriatal Degeneration
by: Yun Jung Bae, et al.
Published: (2022-05-01)
by: Yun Jung Bae, et al.
Published: (2022-05-01)
GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function
by: Tamas L. Horvath, et al.
Published: (2011-07-01)
by: Tamas L. Horvath, et al.
Published: (2011-07-01)
Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome
by: Eva Drnovsek, et al.
Published: (2022-06-01)
by: Eva Drnovsek, et al.
Published: (2022-06-01)
Morpho-physiological Diversity of Cholecystokinin-expressing Interneurons in the Dentate Gyrus
by: Yu-Jui Li, et al.
Published: (2024-10-01)
by: Yu-Jui Li, et al.
Published: (2024-10-01)
Similar Items
-
Characterization of fetal antigen 1/delta-like 1 homologue expressing cells in the rat nigrostriatal system: effects of a unilateral 6-hydroxydopamine lesion.
by: Rémy Liechti, et al.
Published: (2015-01-01) -
l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
by: Christian Winkler, et al.
Published: (2002-07-01) -
GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
by: Susanne Nikolaus, et al.
Published: (2018-03-01) -
Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure
by: Marina Yu. Kopaeva, et al.
Published: (2021-01-01) -
Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat
by: Susanne Nikolaus, et al.
Published: (2021-08-01)
